Lotus Eye Hospital And Institute Ltd (IN:LOTUSEYE)
:LOTUSEYE
Want to see IN:LOTUSEYE full AI Analyst Report?
LOTUSEYE Stock Chart & Stats
₹118.10
-₹0.92(-1.30%)
At close: 4:00 PM EST
₹118.10
-₹0.92(-1.30%)
Day’s Range― - ―
52-Week Range₹68.00 - ₹147.60
Previous CloseN/A
Volume15.88K
Average Volume (3M)2.23K
Market Cap
₹2.25B
Enterprise Value₹2.38B
Total Cash (Recent Filing)₹32.49M
Total Debt (Recent Filing)₹47.99M
Price to Earnings (P/E)2915.2
Beta0.89
Next Earnings
Aug 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.33
Shares Outstanding20,796,330
10 Day Avg. Volume4,541
30 Day Avg. Volume2,230
Financial Highlights & Ratios
PEG Ratio-27.83
Price to Book (P/B)3.28
Price to Sales (P/S)3.68
P/FCF Ratio-18.58
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Specialized Ophthalmology Business ModelA focused ophthalmology platform concentrates clinical expertise, equipment, and consumable sales in a niche medical specialty. That specialization supports repeat patient flows, higher-procedure margins on surgeries and lens sales, and operational know-how that is durable and hard to replicate across general hospitals.
Consistent Revenue Growth TrendSteady mid-single-digit revenue growth indicates persistent demand or expanding service footprint. Over 2-6 months this trend supports recovery potential because top-line momentum gives management room to improve utilization and spread fixed costs if operating efficiency initiatives are executed.
Equity-backed Balance Sheet Provides HeadroomA substantial equity base relative to absolute debt creates capacity to absorb short-term earnings volatility and fund strategic investments or refinancing. This structural capital buffer preserves financial flexibility over the coming months despite a recent uptick in leverage.
Bears Say
Profitability Deterioration Into Operating LossA shift to a slight operating loss undermines internal capital generation and highlights cost-pressure or pricing challenges. Persistently weak operating profitability reduces reinvestment capacity and raises the risk that structural fixes will be needed to restore sustainable margins.
Rapidly Rising LeverageA near fourfold jump in leverage in one year materially reduces financial flexibility and increases interest and refinancing exposure. If earnings remain depressed, higher leverage makes balance-sheet risk more persistent and raises the probability of external funding needs within months.
Deeply Negative Free Cash Flow And Declining Cash ConversionSteep negative free cash flow and shrinking operating cash flow indicate reinvestment or working-capital strain not covered by earnings. This structural cash generation weakness increases funding risk and may force external financing or cutbacks unless operating profitability and cash conversion improve.
Lotus Eye Hospital And Institute Ltd News
LOTUSEYE FAQ
What was Lotus Eye Hospital And Institute Ltd’s price range in the past 12 months?
Lotus Eye Hospital And Institute Ltd lowest stock price was ₹68.00 and its highest was ₹147.60 in the past 12 months.
What is Lotus Eye Hospital And Institute Ltd’s market cap?
Lotus Eye Hospital And Institute Ltd’s market cap is ₹2.25B.
When is Lotus Eye Hospital And Institute Ltd’s upcoming earnings report date?
Lotus Eye Hospital And Institute Ltd’s upcoming earnings report date is Aug 17, 2026 which is in 73 days.
How were Lotus Eye Hospital And Institute Ltd’s earnings last quarter?
Lotus Eye Hospital And Institute Ltd released its earnings results on May 26, 2026. The company reported -₹0.15 earnings per share for the quarter, missing the consensus estimate of N/A by -₹0.15.
Is Lotus Eye Hospital And Institute Ltd overvalued?
According to Wall Street analysts Lotus Eye Hospital And Institute Ltd’s price is currently Overvalued.
Does Lotus Eye Hospital And Institute Ltd pay dividends?
Lotus Eye Hospital And Institute Ltd pays a Annually dividend of ₹0.5 which represents an annual dividend yield of N/A. See more information on Lotus Eye Hospital And Institute Ltd dividends here
What is Lotus Eye Hospital And Institute Ltd’s EPS estimate?
Lotus Eye Hospital And Institute Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lotus Eye Hospital And Institute Ltd have?
Lotus Eye Hospital And Institute Ltd has 20,796,330 shares outstanding.
What happened to Lotus Eye Hospital And Institute Ltd’s price movement after its last earnings report?
Lotus Eye Hospital And Institute Ltd reported an EPS of -₹0.15 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.69%.
Which hedge fund is a major shareholder of Lotus Eye Hospital And Institute Ltd?
Currently, no hedge funds are holding shares in IN:LOTUSEYE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Lotus Eye Hospital And Institute Ltd
Lotus Eye Hospital and Institute Limited, an eye hospital, provides eye care services in India. It offers services in the areas of refractive surgery, retina and uvea, cornea, glaucoma, paediatric and squint, computer vision syndrome, orbit and oculoplasty, neuro ophthalmology, and binocular vision. The company also provides cataract and intraocular lenses, as well as operates an eye bank. In addition, it offers ophthalmic fellowship training courses in cornea, glaucoma, retina, and anterior segments, as well as DNB teaching and training services. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was incorporated in 1997 and is based in Coimbatore, India.
Technical Analysis
Apollo Hospitals Enterprise Limited
―
Aster DM Healthcare Ltd.
―
Fortis Healthcare Ltd.
―
Max Healthcare Institute Ltd
―
Global Health Limited
―